657 related articles for article (PubMed ID: 12183332)
1. Endothelin-1-induced venous contraction is maintained in DOCA-salt hypertension; studies with receptor agonists.
Watts SW; Fink GD; Northcott CA; Galligan JJ
Br J Pharmacol; 2002 Sep; 137(1):69-79. PubMed ID: 12183332
[TBL] [Abstract][Full Text] [Related]
2. Endothelin receptor function in mesenteric veins from deoxycorticosterone acetate salt-hypertensive rats.
Johnson RJ; Fink GD; Watts SW; Galligan JJ
J Hypertens; 2002 Apr; 20(4):665-76. PubMed ID: 11910302
[TBL] [Abstract][Full Text] [Related]
3. NADPH oxidase-derived superoxide augments endothelin-1-induced venoconstriction in mineralocorticoid hypertension.
Li L; Watts SW; Banes AK; Galligan JJ; Fink GD; Chen AF
Hypertension; 2003 Sep; 42(3):316-21. PubMed ID: 12885792
[TBL] [Abstract][Full Text] [Related]
4. Pleiotropic effects of hydrogen peroxide in arteries and veins from normotensive and hypertensive rats.
Thakali K; Davenport L; Fink GD; Watts SW
Hypertension; 2006 Mar; 47(3):482-7. PubMed ID: 16432037
[TBL] [Abstract][Full Text] [Related]
5. Vascular reactivity of mesenteric arteries and veins to endothelin-1 in a murine model of high blood pressure.
Pérez-Rivera AA; Fink GD; Galligan JJ
Vascul Pharmacol; 2005 Jun; 43(1):1-10. PubMed ID: 15975530
[TBL] [Abstract][Full Text] [Related]
6. Effect of an ET(B)-selective and a mixed ET(A/B) endothelin receptor antagonist on venomotor tone in deoxycorticosterone-salt hypertension.
Johnson RJ; Galligan JJ; Fink GD
J Hypertens; 2001 Mar; 19(3):431-40. PubMed ID: 11288813
[TBL] [Abstract][Full Text] [Related]
7. Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension.
Carneiro FS; Nunes KP; Giachini FR; Lima VV; Carneiro ZN; Nogueira EF; Leite R; Ergul A; Rainey WE; Clinton Webb R; Tostes RC
J Sex Med; 2008 Dec; 5(12):2793-807. PubMed ID: 18823320
[TBL] [Abstract][Full Text] [Related]
8. Ovarian hormones modulate endothelin-1 vascular reactivity and mRNA expression in DOCA-salt hypertensive rats.
David FL; Carvalho MH; Cobra AL; Nigro D; Fortes ZB; Rebouças NA; Tostes RC
Hypertension; 2001 Sep; 38(3 Pt 2):692-6. PubMed ID: 11566958
[TBL] [Abstract][Full Text] [Related]
9. Endothelin in the splanchnic vascular bed of DOCA-salt hypertensive rats.
Wang H; Chen AF; Watts SW; Galligan JJ; Fink GD
Am J Physiol Heart Circ Physiol; 2005 Feb; 288(2):H729-36. PubMed ID: 15471983
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological endothelin receptor interaction does not occur in veins from ET(B) receptor deficient rats.
Thakali K; Galligan JJ; Fink GD; Gariepy CE; Watts SW
Vascul Pharmacol; 2008 Jul; 49(1):6-13. PubMed ID: 18485831
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the endothelin ET(B) receptor in gender differences in deoxycorticosterone acetate-salt-induced hypertension.
Kawanishi H; Hasegawa Y; Nakano D; Ohkita M; Takaoka M; Ohno Y; Matsumura Y
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):280-5. PubMed ID: 17324138
[TBL] [Abstract][Full Text] [Related]
12. Gender differences in vascular expression of endothelin and ET(A)/ET(B) receptors, but not in calcium handling mechanisms, in deoxycorticosterone acetate-salt hypertension.
David FL; Montezano AC; Rebouças NA; Nigro D; Fortes ZB; Carvalho MH; Tostes RC
Braz J Med Biol Res; 2002 Sep; 35(9):1061-8. PubMed ID: 12219177
[TBL] [Abstract][Full Text] [Related]
13. Role of ET-1 receptor binding and [Ca(2+)](i) in contraction of coronary arteries from DOCA-salt hypertensive rats.
Giulumian AD; Molero MM; Reddy VB; Pollock JS; Pollock DM; Fuchs LC
Am J Physiol Heart Circ Physiol; 2002 May; 282(5):H1944-9. PubMed ID: 11959662
[TBL] [Abstract][Full Text] [Related]
14. Coronary vascular reactivity is improved by endothelin A receptor blockade in DOCA-salt hypertensive rats.
Giulumian AD; Pollock DM; Clarke N; Fuchs LC
Am J Physiol; 1998 Jun; 274(6):R1613-8. PubMed ID: 9608015
[TBL] [Abstract][Full Text] [Related]
15. p38 mitogen-activated protein kinase contributes to the diminished aortic contraction by endothelin-1 in DOCA-salt hypertensive rats.
Kim B; Kim J; Bae YM; Cho SI; Kwon SC; Jung JY; Park JC; Ahn HY
Hypertension; 2004 May; 43(5):1086-91. PubMed ID: 15051668
[TBL] [Abstract][Full Text] [Related]
16. Decreased endothelin binding and [Ca2+]i signaling in microvessels of DOCA-salt hypertensive rats.
Molero MM; Giulumian AD; Reddy VB; Ludwig LM; Pollock JS; Pollock DM; Rusch NJ; Fuchs LC
J Hypertens; 2002 Sep; 20(9):1799-805. PubMed ID: 12195122
[TBL] [Abstract][Full Text] [Related]
17. Morphological and biochemical characterization of remodeling in aorta and vena cava of DOCA-salt hypertensive rats.
Watts SW; Rondelli C; Thakali K; Li X; Uhal B; Pervaiz MH; Watson RE; Fink GD
Am J Physiol Heart Circ Physiol; 2007 May; 292(5):H2438-48. PubMed ID: 17237246
[TBL] [Abstract][Full Text] [Related]
18. Microvascular responses to endothelin in deoxycorticosterone acetate-salt hypertensive rats.
Zhao H; Joshua IG; Porter JP
Am J Hypertens; 2000 Jul; 13(7):819-26. PubMed ID: 10933575
[TBL] [Abstract][Full Text] [Related]
19. Arterial epidermal growth factor receptor expression in deoxycorticosterone acetate-salt hypertension.
Northcott C; Florian JA; Dorrance A; Watts SW
Hypertension; 2001 Dec; 38(6):1337-41. PubMed ID: 11751714
[TBL] [Abstract][Full Text] [Related]
20. Endothelin-1-induced contraction in isolated aortae from normotensive and DOCA-salt hypertensive rats: effect of magnesium.
Laurant P; Berthelot A
Br J Pharmacol; 1996 Dec; 119(7):1367-74. PubMed ID: 8968545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
